nasdaq:zsan
|
287146
|
Apr 28th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 28th, 2024 01:34AM
|
Apr 28th, 2024 01:34AM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 27th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 26th, 2024 11:53PM
|
Apr 26th, 2024 11:53PM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 26th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 26th, 2024 12:01AM
|
Apr 26th, 2024 09:22AM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 25th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 24th, 2024 11:55PM
|
Apr 25th, 2024 07:34PM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 24th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 24th, 2024 12:04AM
|
Apr 24th, 2024 12:03PM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 23rd, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 22nd, 2024 11:44PM
|
Apr 22nd, 2024 11:44PM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 22nd, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 22nd, 2024 12:53AM
|
Apr 22nd, 2024 12:53AM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 21st, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 21st, 2024 03:30AM
|
Apr 21st, 2024 03:30AM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 20th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 20th, 2024 12:39AM
|
Apr 20th, 2024 05:52PM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|
nasdaq:zsan
|
287146
|
Apr 19th, 2024 12:00AM
|
Zosano Pharma
|
2.6K
|
48.00
|
Open
|
|
Apr 19th, 2024 04:53AM
|
Apr 19th, 2024 04:53AM
|
Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system.
The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action. Zosano Pharma has developed its proprietary transdermal delivery system to administer novel formulations of existing drugs through the skin for the treatment of a variety of indications. The Company’s system offers rapid and consistent drug delivery, improved ease of use and room-temperature stability, all of which are benefits that the Company believes are often unavailable using oral formulations or injections and offer important therapeutic and practical advantages that address unmet needs with large patient populations.
|
Open
|
|
Open
|
34790 Ardentech Court
|
Fremont
|
CA
|
US
|
94555
|
|
Zosano Pharma
|
|
|